Company Filing History:
2 out of 321 
1 out of 549 
1 out of 1,572 
Years Active: 2017-2024
Title: Se Mi Kim: Innovator in Antibody Development
Introduction
Se Mi Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 2 patents, his work focuses on innovative solutions for medical challenges.
Latest Patents
Se Mi Kim's latest patents include the development of TM4SF5-targeting humanized antibodies and their applications. The first patent relates to TM4SF5-specific humanized antibodies, which are designed to bind specifically to the TM4SF5 protein. The second patent describes a novel monoclonal antibody that targets the TM4SF5 protein, detailing its potential uses in treating liver fibrosis and cancer. This invention encompasses methods for diagnosing cancer and inhibiting its metastasis, showcasing the versatility and importance of his research.
Career Highlights
Throughout his career, Se Mi Kim has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and the SNU RDB Foundation. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Se Mi Kim has collaborated with notable colleagues, including Jung Weon Lee and Sang Jick Kim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Se Mi Kim's contributions to the field of biotechnology, particularly in antibody development, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for various diseases.